Background: Our previous study suggested newborns have competent immune sys-
suggesting the presence of maternal antibodies may dampen or interfere with the infant's primary antibody response to infections or immunizations. [8] [9] [10] [11] [12] However, one human infant study examining the relationship between levels of specific antibody concentration at birth and subsequent response to primary immunization showed the majority of infants generated high levels of antibodies postimmunization, suggesting high levels of maternally derived antibody at birth may not inhibit infant immunization responses in a clinically relevant manner. 
| MATERIALS AND METHODS

| Animals and ethics statement
A total of eight female Indian-origin rhesus macaques (Macaca mulatta)
and their paired eight infants were examined as shown in Table 1 .
Eight infants were obtained from their dams at birth, and nursery- 
| Vaccination and sample collection
All eight dams were intramuscularly vaccinated twice with 0.5 mL tetanus toxoid (TT) vaccine, (Statens Serum Institute, Copenhagen) before pregnancy as shown as in Table 1 . Four of eight newborns were intramuscularly immunized once with 0.5 mL TT within 24 hours of birth, and another four were not immunized and served as unvaccinated controls. Plasma samples were collected from all dams and their newborns at birth. Blood from all infants was collected either biweekly or monthly for at least 6 months beginning at 2 weeks of birth. All plasma samples were kept at -80°C until use.
| Detection of anti-TT IgG1 antibodies in plasma of rhesus macaques
To quantify levels of anti-TT IgG1 in plasma, Monkey Anti-TT IgG1
ELISA kits were used (Life Diagnostics, PA, USA) as previously described. 14 Briefly, each plasma sample was diluted to the optimal concentration with diluent buffer provided by the kits, and run in duplicate on the plates as per manufacture's instruction. Following development with TMB substrate, optical densities (ODs) were measured at 450 nm using a BioTek™ Synergy™ H4 Hybrid Microplate
Reader. Standard curves were determined from controls, and the results were expressed as μg/mL. All samples were run in duplicate with appropriate positive and negative controls, and the minimum detection limit for anti-TT IgG1 antibodies was 20-30 μg/mL based on negative controls.
| Statistics analysis
Graphical presentation and statistical analysis were performed using GraphPad Prism 6.0 (GraphPad Software Inc., SanDiego, CA, USA).
The arithmetic mean concentrations of plasma anti-TT IgG1 from four infant macaques of each group were used for comparisons between groups and analyzed by a two-tailed paired t-test. The Mann-Whitney test was used to evaluate whether differences between two groups were statistically significant as defined by P values. Pearson correlations were used to compare antibody levels between dams and infants. P values ≤0.05 were considered statistically significant. 
T A B L E 1 Vaccination strategies in rhesus macaques
| RESULTS
| Levels of tetanus toxoid-specific IgG1 in newborns highly correlated with their respective dam at birth
Placental transfer of maternal IgG antibodies to the fetus provides protection for the offspring from potential infections in early life, and the transfer of antibodies against viral proteins and antitoxins of the IgG1 subclass occurs more readily. 15 We first examined levels of 
| Significant high levels of plasma anti-TT IgG1 among vaccinated infant macaques after 6 months post-vaccination
Similar to the dams, levels of anti-TT IgG1 varied among the eight newborns at birth, and there were no significant differences in levels of maternal anti-TT IgG1 levels between vaccinated (Mean=357.3;
95% CI of mean from −478 to 1193) and unvaccinated groups (Mean=457.5; 95% CI of mean from −79.8 to 994.8) on the day of birth as shown as in Figure 2 . Surprisingly, however, we found much higher levels of plasma anti-TT IgG1 in vaccinated infant macaques (Mean=2318; 95% CI of mean from 418.1 to 4219) when compared to unvaccinated infants (Mean=19.35; 95% CI of mean from 13.88 to 24.82) 6 months post-vaccination, suggesting remarkable vaccine responses in these infants despite receiving the vaccination on the day of birth, when levels of maternal antibodies to TT were high.
| Maternal antibody may not suppress infants from generating anti-TT IgG1 responses to vaccination
By following changes of anti-TT IgG1 in all eight infants, we found, as 
| DISCUSSION
Neonates are vulnerable to many infectious diseases, and vaccination in early life provides significant protection against many infectious diseases and decreases infant mortality. 16 However, most vaccines are not administered in the first month of life mainly due to concepts of an "immature" immune system and the possibility of interference by passively acquired maternal antibodies. In this study, we demonstrated infant macaques were able to generate rapid and high levels of antibodies in response to one dose of TT vaccine received on the day of birth, despite the presence of significant levels of autologous maternal Combined, these findings indicate that the newborn immune system is competent, and fully capable of responding to vaccination on the day of birth (at least for the TT vaccine) despite the presence of high levels of maternal antibody. As we also observed different kinetics of plasma anti-TT IgG1 levels in the four vaccinated infants, we cannot rule out the possibility of maternal antibody titer-dependent suppressive effects. Therefore, further studies with greater sample sizes and unvaccinated dam controls are needed to definitively prove whether these induced antibodies are indeed protective from infection, and whether it would be beneficial to schedule the first vaccinations as close to the day of birth as possible in order to increase the window of protection from infectious disease in infants.
F I G U R E 3 Changes in anti-tetanus IgG1 antibody (Ab) levels in neonatal macaques vaccinated with TT on the day of birth (solid lines) and unvaccinated controls (dash lines). As expected, all infants had maternal Ab to tetanus on the day of birth, but their levels were ranged. In addition, marked antibody responses to vaccination were detected in all four vaccinated infants (NB5-8), whereas levels of maternal Abs continuously declined in all four unvaccinated infants (NB1-4)
